ENCYCLE THERAPEUTICS INC has a total of 23 patent applications. It increased the IP activity by 20.0%. Its first patent ever was published in 2015. It filed its patents most often in EPO (European Patent Office), Canada and China. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are CHENGDU AODA BIOLOGICAL TECH CO LTD, TRANZYME PHARMA INC and BIOCAD CJSC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 5 | |
#2 | Canada | 4 | |
#3 | China | 4 | |
#4 | United States | 4 | |
#5 | WIPO (World Intellectual Property Organization) | 4 | |
#6 | Republic of Korea | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Vazquez Manuel Perez | 21 |
#2 | Hickey Jennifer L | 21 |
#3 | Kafal Adam Paul | 20 |
#4 | Roughton Andrew L | 12 |
#5 | Morshed M Monzur | 12 |
#6 | Yang Gaoqiang | 11 |
#7 | Roughton Andrew | 11 |
#8 | Gillard James | 11 |
#9 | Chakka Sai Kumar | 10 |
#10 | Poupart Marc-Andre | 6 |
Publication | Filing date | Title |
---|---|---|
EP3621980A1 | Homodetic cyclic peptides targeting alpha4 beta7 1ntegrin | |
WO2018085921A1 | CYCLIC PEPTIDES MULTIMERS TARGETING α4β7 INTEGRIN | |
EP3221335A1 | Solid phase synthesis of cyclic amino acid molecules |